Sign in

CIK 0001868279 · Non-accelerated filer<br>Emerging growth company

ArriVent BioPharma, Inc.

Sign in to watch
Ticker
AVBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
240-780-6356
Business address
18 CAMPUS BLVD., SUITE 100, NEWTOWN SQUARE, PA, 19073-3269
  1. 8-K Event Results of operations
  2. DEF 14A Proxy Proxy Statement
  3. 8-K Event Executive or director change · Regulation FD disclosure
  4. 8-K Event Auditor change
  5. 8-K Event Results of operations
  6. 10-K Report Annual Report
  7. 8-K Event Material agreement · Regulation FD disclosure
  8. 8-K Event Results of operations
  9. 8-K Event Regulation FD disclosure · Other events
  10. 8-K Event Results of operations
  11. 8-K/A Event Executive or director change
  12. 8-K/A Event Executive or director change
  13. 8-K Event Material agreement · Regulation FD disclosure
  14. 8-K Event Executive or director change
  15. 8-K Event Results of operations
  16. 8-K Event Executive or director change
  17. 10-K Report Annual Report
  18. 8-K Event Results of operations
  19. 8-K Event Bylaws or fiscal year change · Other events

Page 2 of 2 · 39 filings